Penn Medicine Provider
Infectious Diseases
Michael Z. David, MD, PhD
4.8
(55)
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program

About me

  • Director, Methicillin-Resistant Staphylococcus aureus Program
  • Associate Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
  • Associate Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: Yale University
  • Residency: Yale-New Haven Hospital
  • Fellowship: University of Chicago Medical Center

What my patients think about me

Average Rating
4.8

55 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
gives answers to questions and does nor rush.
March 2025
5.0
5.0
he is simply the best doctor for id
March 2025
5.0
5.0
i am very happy with him as a provider.
February 2025
5.0
5.0
my medical issue is this doctor's specialty. he is expert, concerned and open to information.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. David is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

David MZ MRSA community pneumonia: A global perspective on resistance , Lancet Infect Dis, 16(12): 2016,1309-10


Alam T, Reed T, Sieth J, Kumar N, Miller LG, Eells S, Boyle-Vavra S, Daum RS, David MZ Transmission and microevolution of USA300 MRSA in U.S. households: Evidence from whole-genome sequencing , mBio, 6(2): 2015,e00054-15


David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM Recently approved new antibacterials for Gram positive bacteria: The shock of the new , Int J Antimicrob Agents, 50(3): 2017,303-307


Azarian T, Petty L, Steinbeck J, Michel A, Yin Z, Boyle-Vavra S, Daum RS, David MZ Intrahost evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft-tissue infections , J Infect Dis, 214(6): 2016,895-905


Carrel M, Perencevich E, David MZ USA300 methicillin-resistant Staphylococcus aureus, United States, 2000-2013 , Emerg Infect Dis, 21(11): 2015,1973-80


Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS Impact of Staphylococcus aureus USA300 colonization and skin infections on systemic immune responses in humans , J Immunol, 197(4): 2016,1118-1126


David MZ, Siegel JD, Henderson J, Leos G, Lo K, Porsa E, Schumm P, Boyle-Vavra S, Daum RS A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail , Infect Control Hosp Epidemiol, 35(12): 2014,1466-73


Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS Staphylococcus aureus skin infection recurrences among household members: An examination of host, behavioral, and pathogen level predictors , Clin Infect Dis, 60(5): 2015,753-63


Shah N, McNulty M, Greenberg JA, Riddell J, Gregg KS, Mangino JE, Weber D, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino C, Green Hines A, Bares S, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14 , J Clin Virol, 80(1): 2016,12-19


View all publications